Efficacy of bedaquiline in the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis

QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial

(2021) Kelly E Dooley et al.   LANCET INFECTIOUS DISEASES

New TB drugs for the treatment of children and adolescents with rifampicin-resistant TB in Mumbai, India

(2020) M. Das et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Adverse drug reactions in South African patients receiving bedaquiline-containing tuberculosis treatment: an evaluation of spontaneously reported cases

(2019) Jackie Jones et al.   BMC INFECTIOUS DISEASES

Bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis: a multicentre cohort study in Korea

(2018) Cheon Tae Kim et al.   EUROPEAN RESPIRATORY JOURNAL

Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa

(2018) Olatunde Olayanju et al.   EUROPEAN RESPIRATORY JOURNAL

Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study

(2018) Kathryn Schnippel et al.   Lancet Respiratory Medicine

Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort Study

(2018) Ying Zhao et al.   CLINICAL INFECTIOUS DISEASES

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

(2017) Sergey E. Borisov et al.   EUROPEAN RESPIRATORY JOURNAL

Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis

(2015) Alexander S. Pym et al.   EUROPEAN RESPIRATORY JOURNAL

Compassionate Use of Bedaquiline for the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Interim Analysis of a French Cohort

(2014) L. Guglielmetti et al.   CLINICAL INFECTIOUS DISEASES

Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline

(2014) Andreas H. Diacon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

TMC207: the first compound of a new class of potent anti-tuberculosis drugs

(2010) Alberto Matteelli et al.   Future Microbiology